2006 Clinical Trials Data Topical 
Greencamp
AUGUST 16, 2018
The first study I will reference is from 2006, conducted on mice. Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease.”.
Greencamp
FEBRUARY 2, 2019
Even though scientific data is still somewhat scarce on this topic, several studies confirm that cannabis directly acts on the cells of the immune system affected by HIV. It will be the biggest and most comprehensive research on this topic to date, and it will include 400 HIV patients from Florida. 2016 ( 3 ).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
OCTOBER 7, 2019
In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. In 2006, a medication called rimonabant – which acted as a selective CB1 antagonist/inverse agonist – was approved in 30 countries for the treatment of obesity. Believe it or not, science says: YES.
Cannabis Law Report
NOVEMBER 24, 2021
At the same time, the outlook on cannabis research data is largely positive. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Cell Calcium 39 (2006) 155–162.
Expert insights. Personalized for you.
94 
Let's personalize your content